AU2002350157A1 - Polycyclic guanine derivative phosphodiesterase v inhibitors - Google Patents

Polycyclic guanine derivative phosphodiesterase v inhibitors

Info

Publication number
AU2002350157A1
AU2002350157A1 AU2002350157A AU2002350157A AU2002350157A1 AU 2002350157 A1 AU2002350157 A1 AU 2002350157A1 AU 2002350157 A AU2002350157 A AU 2002350157A AU 2002350157 A AU2002350157 A AU 2002350157A AU 2002350157 A1 AU2002350157 A1 AU 2002350157A1
Authority
AU
Australia
Prior art keywords
inhibitors
guanine derivative
polycyclic guanine
phosphodiesterase
derivative phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350157A
Inventor
Theodros Asberom
John W. Clader
Yueqing Hu
Dmitri A. Pissarnitski
Andrew W. Stamford
Ruo Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2002350157A1 publication Critical patent/AU2002350157A1/en
Abandoned legal-status Critical Current

Links

AU2002350157A 2001-11-09 2002-11-07 Polycyclic guanine derivative phosphodiesterase v inhibitors Abandoned AU2002350157A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/344,498 2001-11-09

Publications (1)

Publication Number Publication Date
AU2002350157A1 true AU2002350157A1 (en) 2003-05-26

Family

ID=

Similar Documents

Publication Publication Date Title
HK1064668A1 (en) Polycyclic guanine phosphodiesterase v inhibitors
EP1436290B8 (en) Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor
IL152872A0 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
HK1066546A1 (en) Trifluoromethylpurines as phosphodiesterase 4 inhibitors
AU1025899A (en) Carboline derivatives as cgmp phosphodiesterase inhibitors
AU2002357773A1 (en) 1,6 naphthyridines useful as inhibitors of syk kinase
AU2002354224A1 (en) Novel phenylalanine derivative
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
IL156958A0 (en) Aniline derivatives useful as phosphodiesterase 4 inhibitors
AU2003281477A1 (en) 4-amino-substituted pyrimidine derivatives
AU2003254051A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2002362806A1 (en) Pyrimidine derivatives
AU2003249658A1 (en) Xanthine phosphodiesterase v inhibitor polymorphs
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2002365664A1 (en) Quinoline derivatives as antitumour agents
AU2002224835A1 (en) Dihydroisoquinolines as novel phosphodiesterase inhibitors
AU2001271948A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors
AUPS251402A0 (en) Kinase inhibitors
AU2002350157A1 (en) Polycyclic guanine derivative phosphodiesterase v inhibitors
AU2001233965A1 (en) Novel cd23 inhibitors
AU2002326765A1 (en) Polycyclic guanine phosphodiesterase v inhibitors